Home » Topics » BioWorld Science

BioWorld Science
RSS

Nippon Steel discloses anticoagulant, antithrombotic peptide

May 10, 1996

Advisory committee refuses to recommend Coreg approval for CHF

May 10, 1996

Structure revealed for UK-1745

May 10, 1996

Structure disclosed for KCB-328

May 10, 1996

More Na+/H+-exchange inhibitors from Hoechst

May 10, 1996

Na+/H+-exchange inhibitors revealed by E. Merck

May 10, 1996

Cylexin phase II results announced

May 10, 1996

Zynaxis to develop Zyn-Linker form of paclitaxel for restenosis Rx

May 10, 1996

Cardioprotective activity of LU-51198 demonstrated in animal model

May 10, 1996

5-HT2 antagonists claimed by Toa Eiyo

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...